Dendritic cell-based therapeutic vaccine elicits polyfunctional HIV-specific T-cell immunity associated with control of viral load

European Journal of Immunology

Volumn 44, Issue 9, 2014, Pages 2802-2810

  Lévy, Yves ^a,b,c,d   Thiébaut, Rodolphe ^a,d,e,f   Montes, Monica ^d,g,h   Lacabaratz, Christine ^a,b,d   Sloan, Louis ^g,i   King, Bryan ⁱ   Pérusat, Sophie ^a,e   Harrod, Carson ^d,g,h   Cobb, Amanda ^g,h   Roberts, Lee K ^g   Surenaud, Mathieu ^a,b,d   Boucherie, Céline ^a   Zurawski, Sandra ^d,g,h   Delaugerre, Constance ^j   Richert, Laura ^a,d,e,f   Cĥene, Geneviève ^a,d,e   Banchereau, Jacques ^a,b,d,g,h,k   Palucka, Karolina ^d,g,h  

^a INSERM   (France)

^b UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d Vaccine Research Institute   (France)

^e UNIVERSITÉ DE BORDEAUX   (France)

^f INRIA   (France)

^g BAYLOR INSTITUTE FOR IMMUNOLOGY RESEARCH   (United States)

^h INSERM U899   (United States)

ⁱ North Texas Infectious Diseases Consultants   (United States)

^j SAINT LOUIS HOSPITAL   (France)

^k JACKSON LABORATORY   (United States)

more..

Author keywords

Antiretroviral therapy interruption; Dendritic cell; Lipopeptides; T cells; Vaccination

Indexed keywords

CYTOKINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; LIPOPEPTIDE;

ADULT; ANTIRETROVIRAL THERAPY INTERRUPTION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DENDRITIC CELL; DRUG EFFECT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MALE; MULTICENTER STUDY; PHASE 1 CLINICAL TRIAL; PHYSIOLOGY; T CELLS; VACCINATION; VIRUS LOAD; VIRUS REPLICATION;

ANTIRETROVIRAL THERAPY INTERRUPTION; DENDRITIC CELL; LIPOPEPTIDES; T CELLS; VACCINATION;

ADULT; AIDS VACCINES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; DENDRITIC CELLS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LIPOPEPTIDES; MALE; VACCINATION; VIRAL LOAD; VIRUS REPLICATION;

EID: 84907841767     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201344433     Document Type: Article

References (29)

1. Rerks-Ngarm, S., Pitisuttithum, P., Nitayaphan, S., Kaewkungwal, J., Chiu, J., Paris, R., Premsri, N. et al., Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N. Engl. J. Med. 2009. 361: 2209-2220.
2. Scheid, J. F., Mouquet, H., Feldhahn, N., Seaman, M. S., Velinzon, K., Pietzsch, J., Ott, R. G. et al., Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals. Nature. 2009. 458: 636-640.
3. Haynes, B. F., Gilbert, P. B., McElrath, M. J., Zolla-Pazner, S., Tomaras, G. D., Alam, S. M., Evans, D. T. et al., Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N. Engl. J. Med. 2012. 366: 1275-1286.
4. Levy, Y., Preparation for antiretroviral interruption by boosting the immune system. Curr. Opin. HIV AIDS. 2008. 3: 118-123.
5. Garcia, F. and Routy, J. P., Challenges in dendritic cells-based therapeutic vaccination in HIV-1 infection Workshop in dendritic cell-based vaccine clinical trials in HIV-1. Vaccine 2011. 29: 6454-6463.
6. Lu, W., Arraes, L. C., Ferreira, W. T. and Andrieu, J. M., Therapeutic dendritic-cell vaccine for chronic HIV-1 infection. Nat. Med. 2004. 10: 1359-1365.
7. Garcia, F., Climent, N., Guardo, A. C., Gil, C., Leon, A., Autran, B., Lifson, J. D. et al., A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication. Sci. Transl. Med. 2013. 5: 166ra2.
8. Van Gulck, E., Vlieghe, E., Vekemans, M., Van Tendeloo, V. F., Van De Velde, A., Smits, E., Anguille, S. et al.,mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients. AIDS 2012. 26: F1-12.
9. Cobb, A., Roberts, L. K., Palucka, A. K., Mead, H., Montes, M., Ranganathan, R., Burkeholder, S. et al., Development of a HIV-1 lipopeptide antigen pulsed therapeutic dendritic cell vaccine. J. Immunol. Methods 2011. 365: 27-37.
10. Pantaleo, G. and Koup, R. A., Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know. Nat. Med. 2004. 10: 806-810.
11. Pantaleo, G. and Harari, A., Functional signatures in antiviral T-cell immunity for monitoring virus-associated diseases. Nat. Rev. Immunol. 2006. 6: 417-423.
12. Potter, S. J., Lacabaratz, C., Lambotte, O., Perez-Patrigeon, S., Vingert, B., Sinet, M., Colle, J. H. et al., Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study. J. Virol. 2007. 81: 13904-13915.
13. Saez-Cirion, A., Lacabaratz, C., Lambotte, O., Versmisse, P., Urrutia, A., Boufassa, F., Barre-Sinoussi, F. et al., HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype. Proc. Natl. Acad. Sci. U S A 2007. 104: 6776-6781.
14. Williams, L. D., Bansal, A., Sabbaj, S., Heath, S. L., Song, W., Tang, J., Zajac, A. J. et al., Interleukin-21-producing HIV-1-specific CD8 T cells are preferentially seen in elite controllers. J. Virol. 2011. 85: 2316-2324.
15. Frohlich, A., Kisielow, J., Schmitz, I., Freigang, S., Shamshiev, A. T., Weber, J., Marsland, B. J. et al., IL-21R on T cells is critical for sustained functionality and control of chronic viral infection. Science (80). 2009. 324: 1576-1580.
16. Lichterfeld, M., Kaufmann, D. E., Yu, X. G., Mui, S. K.,Addo, M. M., Johnston, M. N., Cohen, D. et al., Loss of HIV-1-specific CD8(+) T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4(+) T cells. J. Exp. Med. 2004. 200: 701-712.
17. Sun, J. C., Williams, M. A. and Bevan, M. J., CD4+ T cells are required for the maintenance, not programming, ofmemory CD8+ T cells after acute infection. Nat. Immunol. 2004. 5: 927-933.
18. Kalams, S. A. and Walker, B. D., The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses. J. Exp. Med. 1998. 188: 2199-2204.
19. Rosenberg, E. S., Billingsley, J. M., Caliendo, A. M., Boswell, S. L., Sax, P. E., Kalams, S. A. and Walker, B. D., Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science (80). 1997. 278: 1447-1450.
20. Hel, Z., Nacsa, J., Tryniszewska, E., Tsai, W. P., Parks, R. W., Montefiori, D. C., Felber, B. K. et al., Containment of simian immunodeficiency virus infection in vaccinated macaques: correlation with the magnitude of virus-specific pre- and postchallenge CD4+ and CD8+ T cell responses. J. Immunol. 2002. 169: 4778-4787.
21. Betts, G. J., Clarke, S. L., Richards, H. E., Godkin, A. J. and Gallimore, A. M., Regulating the immune response to tumours. Adv. Drug Deliv. Rev. 2006. 58: 948-961.
22. Hersperger, A. R., Pereyra, F., Nason, M., Demers, K., Sheth, P., Shin, L. Y., Kovacs, C. M. et al., Perforin expression directly ex vivo by HIVspecific CD8 T-cells is a correlate of HIV elite control. PLoS Pathog. 2010. 6: e1000917.
23. Klechevsky, E., Flamar, A. L., Cao, Y., Blanck, J. P., Liu, M., O'Bar, A., Agouna-Deciat, O. et al., Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR. Blood 2010. 116: 1685-1697.
24. Gahery-Segard, H., Pialoux, G., Charmeteau, B., Sermet, S., Poncelet, H., Raux, M., Tartar, A. et al., Multiepitopic B- and T-cell responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine. J. Virol. 2000. 74: 1694-1703.
25. Levy, Y., Thiebaut, R., Gougeon, M. L., Molina, J. M., Weiss, L., Girard, P. M., Venet, A. et al., Effect of intermittent interleukin-2 therapy on CD4+ T-cell counts following antiretroviral cessation in patients with HIV. AIDS. 2012. 26: 711-720.
26. Levy, Y., Gahery Segard, H., Durier, C., Lascaux, A. S., Goujard, C., Meiffredy, V., Rouzioux, C. et al., Immunological and virological efficacy of a therapeutic immunization combined with interleukin-2 in chronically HIV-1 infected patients. AIDS. 2005. 19: 279-286.
27. Wittkowski, K. M., Lee, E., Nussbaum, R., Chamian, F. N. and Krueger, J. G., Combining several ordinal measures in clinical studies. Stat. Med. 2004. 23: 1579-1592.
28. Benjamini, Y. and Yekutieli, D., The control of the false discovery rate in multiple testing under dependency. Ann. Stat. 2001. 29: 1165-1188.
29. Benjamini, Y. and Hochberg, Y., On the adaptive control of the false discovery rate in multiple testing with independent statistics. J. Educ. Behav. Stat. 2000. 25: 60-83.